CPT Code 11643: Excision of malignant lesion, face, 2.1 to 3.0 cm

Key takeaways

CPT Code 11643 describes excision of a malignant lesion, including margins, from the face, ears, eyelids, nose, lips, or mucous membranes. The excised diameter measures 2.1 to 3.0 cm, a mid-tier size in the series, not the largest.

The excised diameter includes the lesion plus margins – not the visible lesion alone. Using the lesion-only measurement is one of the most common coding errors for this family.

Modifier -59 applies when multiple lesions are excised at the same encounter; modifiers -LT/-RT clarify laterality for paired structures such as ears or eyelids.

Practice management software like Pabau attaches ICD-10 pairings, modifiers, and pathology documentation to each patient encounter, keeping dermatology and plastic surgery billing records complete.

Claim denials for excision codes are rarely about the procedure itself. They happen because the excised diameter was measured incorrectly, the wrong ICD-10 code was paired, or the pathology report wasn’t attached before submission. CPT Code 11643 sits in the middle of the malignant facial excision series. The 2.1 to 3.0 cm threshold covers moderate-sized wounds that often need more than a simple linear closure. Reimbursement scrutiny scales up further for the larger codes above it. Getting the documentation and code selection right the first time is what separates clean claims from costly rework.

This reference covers the full coding picture for CPT Code 11643: the official AMA descriptor, the adjacent 1164x series codes, and applicable ICD-10-CM pairings. It also covers modifier usage, 2026 Medicare reimbursement, RVU components, and documentation requirements that satisfy both Medicare and commercial payer audits.

What is CPT Code 11643?

CPT Code 11643 is the AMA CPT codebook’s descriptor for excision of a malignant lesion including margins. It applies to the face, ears, eyelids, nose, lips, and mucous membranes when the excised diameter is 2.1 to 3.0 cm. It falls within the Integumentary System section under Excision – Malignant Lesions Procedures on the Skin.

The anatomic sites covered are specific. This code applies only to the face and facial structures listed. Excisions of the same size on the scalp, neck, hands, feet, or trunk use different codes from an adjacent series. Selecting the wrong anatomic family is a leading reason dermatology and plastic surgery claims are rejected on initial submission.

One detail coders miss: the size threshold applies to the excised specimen, not the clinical lesion measurement documented in the pre-operative note. The surgeon excises the lesion plus a margin of normal tissue. That total diameter is what determines code selection. Practices using structured documentation software that prompts for the post-excision measurement at the point of care catch this discrepancy before billing, not after a denial.

CPT Code 11643 in the 1164x series: comparing adjacent codes

The malignant facial excision codes form a size-based ladder. Each code in the 1164x series covers the same anatomic sites but a different excised diameter range. Selecting the wrong rung is an easy error when pre-operative and post-excision measurements differ.

Coding note: The 1164x facial series has no code numbered 11645. The range jumps from 11644 (3.1 to 4.0 cm) straight to 11646 (over 4.0 cm). Coders should still confirm current-year diameter ranges in the official AAPC CPT code lookup or the AMA CPT manual before submitting claims. Descriptors can change with each annual update. Other codes outside the 1164x facial series cover malignant excisions on the scalp, neck, trunk, arms, and legs.

The same size-based logic shapes coding decisions outside this series too. 21048 covers benign tumor excision at the maxilla under its own diameter thresholds.

ICD-10 codes used with CPT Code 11643

Every claim for CPT Code 11643 requires an ICD-10-CM diagnosis code that confirms malignancy. Medicare and most commercial payers will reject a claim that pairs this code with a benign or unspecified skin lesion diagnosis. The most common pairings fall into three cancer categories: basal cell carcinoma, squamous cell carcinoma, and melanoma.

ICD-10-CM codes are updated annually. Verify all pairings against the CDC/NCHS ICD-10-CM web tool for the current fiscal year before submission. The most specific code available should always be used. Payers that review excision claims expect the laterality and anatomic site to align precisely with the operative note. Practices managing dermatology EMR workflows benefit from templates that link pre-selected ICD-10 pairings to each procedure type.

Modifiers for CPT Code 11643

Modifier usage for malignant excision codes is payer-sensitive. Applying a modifier incorrectly is one of the top denial triggers in dermatology billing – and applying no modifier when one is required is equally costly. The table below covers the modifiers most commonly associated with this code.

Modifier guidance must be verified against individual payer policies and current National Correct Coding Initiative (NCCI) edits. The -59 modifier in particular carries audit risk – CMS and commercial payers scrutinize its use when multiple excision codes are billed on the same date. Practices using digital clinical forms prompt for per-lesion documentation at the point of care. That reduces the chance of a -59 denial, because the supporting record is already complete before the claim is built.

Reimbursement and 2026 Medicare fee schedule

Medicare reimburses CPT Code 11643 through the Physician Fee Schedule (PFS), calculated using Relative Value Units multiplied by the annual conversion factor. The 2026 national average reimbursement reflects work, practice expense, and malpractice RVU components. Geographic Practice Cost Index (GPCI) adjustments mean practices in high-cost metropolitan areas receive higher payments than the national average, while rural markets receive less.

For verified 2026 payment rates, use the CMS Physician Fee Schedule search tool, which reflects the most current national and locality-specific rates. The figures below represent illustrative RVU components based on published CMS data; always confirm current-year values before quoting reimbursement to staff or patients.

RVU breakdown for CPT Code 11643

Private payer contracts typically reimburse at a percentage of the Medicare fee schedule, though rates vary considerably by payer, geographic market, and contract tier. Practices with plastic surgery billing workflows that track payer-specific reimbursement by CPT code can benchmark actual payments against expected Medicare rates. This helps identify underpayment patterns before they compound.

Documentation requirements for excision of malignant lesions

According to CMS Medicare Coverage Database guidance (article ID 57660), pathological confirmation of malignancy is required for Medicare coverage of malignant skin lesion excision codes. Submitting CPT Code 11643 without a pathology report in the medical record is the single most common reason these claims fail a post-payment audit.

• Pathology report: Confirms the lesion is malignant. Must be in the record before the claim is finalized. If results are pending, bill only after confirmation.
• Operative note: Describes the lesion location, the excision technique, and the measured dimensions of the excised specimen including margins.
• Excised diameter measurement: Must reflect the post-excision specimen size (lesion plus margins), not the pre-operative clinical estimate.
• Anatomic site specificity: Note should name the exact site (e.g., left nasal ala, right lower eyelid) to support the ICD-10 code selected.
• Margin status: Document whether margins are clear or involved. This affects subsequent care coding and supports medical necessity for any re-excision.
• Repair documentation: If a repair code is billed alongside the excision, the operative note must describe the repair separately. It must also justify that the repair is not a component of the excision itself.

Practices that digitize their operative note workflow can build these documentation checkpoints directly into their procedure note templates. That reduces the chance a required field is left blank under time pressure. Dermatology teams that also manage HIPAA-compliant records management need to store pathology reports in the patient record. These should sit alongside the encounter note before a claim is submitted.

Billing guidelines and common denial reasons

The majority of denials for CPT Code 11643 fall into four patterns. Understanding each one in advance is cheaper than appealing after the fact.

Wrong size measurement

The excised diameter is measured at the time of excision, not from a pre-operative assessment. The operative note might record a 3.8 cm lesion clinically, but the excised specimen with margins could measure 4.3 cm. In that case, the correct code is 11646, or whichever code covers that excised diameter, not a code based on the pre-excision size. Coders who work from clinical notes rather than operative notes introduce systematic miscoding.

Repair code bundling errors

Simple repairs (12011-12018) are generally considered bundled into the excision code under NCCI edits. Intermediate and complex repairs may be separately billable with appropriate documentation, but eligibility is payer-specific. Assuming all repair codes can be separately billed is one of the most expensive billing errors in dermatology. Payers apply automatic bundling edits and will reject the repair code line without notice. Verify current NCCI edits before billing any repair code alongside an excision.

Mismatched ICD-10 diagnosis

Pairing CPT Code 11643 with a benign lesion diagnosis code or an unspecified skin lesion code produces an automatic medical-necessity denial. The same applies to an ICD-10 code for a different anatomic site. The diagnosis must specify malignancy and match the anatomic site described in the operative note and coded in the CPT selection. The same cross-referencing discipline applies to other procedure families too. For 11044, which covers bone debridement, the diagnosis code must match the documented site just as precisely.

Missing or late pathology report

Medicare and most commercial payers require pathological confirmation of malignancy as a coverage condition. Billing before the pathology result is finalized, or billing without the report stored in the medical record, produces both claim denials and audit liability. Practices using lab management software can flag pending pathology results and hold claims in a queue until the report arrives. This avoids releasing them prematurely.

How Pabau simplifies billing for dermatology and plastic surgery excision codes

Dermatology and plastic surgery practices billing malignant excision codes face a specific documentation burden. Every claim requires a pathology report, a size-confirmed operative note, a site-specific ICD-10 code, and potentially one or more modifiers. These elements often live in separate systems: a paper chart, a lab portal, a billing platform, and a modifier cheat sheet.

Pabau’s structured records link procedure notes, ICD-10 codes, modifier selections, and attached documents, including pathology reports, to the same encounter record. Before a claim is built, the system prompts the billing team to confirm every required field is populated. That completeness check is where most of the denial types described above get caught.

Practices also benefit from Pabau’s digital forms capability, which lets clinical teams build lesion-specific documentation templates directly into the procedure workflow. A template can prompt for post-excision diameter, margin status, anatomic site, and pathology status before the note is finalized. The result is a complete record that supports both the CPT code selection and the ICD-10 pairing.

For practices managing a high volume of skin cancer excisions, Pabau is developing Insights Plus, an additional reporting add-on not yet live. Once available, it is designed to let revenue cycle teams track denial rates by procedure code and measure documentation improvements over time.

Dermatology and plastic surgery practices can see how Pabau structures the billing workflow for excision codes. Reviewing similar practices already on the platform shows this approach in action. The same documentation discipline extends to routine dermatology procedures, including 11056 for paring corns and calluses. The clinical forms approach to documentation described in Pabau’s resource library is also relevant for practices building standardized operative note templates.

Reduce claim denials for excision codes

Pabau attaches ICD-10 pairings, modifiers, and pathology documentation to each patient encounter, helping dermatology and plastic surgery teams catch errors before billing.

Book a demo

Conclusion

CPT Code 11643 sits in the middle of the malignant facial excision series, covering excised diameters of 2.1 to 3.0 cm. It is neither the smallest nor the largest code in the family. Accurate coding still depends on three things. Measure the excised specimen, not the clinical lesion. Attach pathology confirmation before submission, and select the ICD-10 code that matches both the cancer type and the exact anatomic site.

Practice management software like Pabau gives dermatology and plastic surgery teams the structure to get these elements right at the point of care. That beats fixing them after a denial. To see how Pabau handles excision code billing workflows in practice, book a demo with the team.

Continue your research

Coding an excision outside the facial 1164x series? 21048 covers benign tumor excision at the maxilla under its own size-based rules.

Billing bone debridement alongside an excision? 11044 walks through the documentation this excision-adjacent code requires.

Want to reduce claim errors across all procedure codes? HIPAA compliance checklist for primary care covers the documentation standards that apply across all billable procedure types.

Frequently asked questions